Mefloquine

Edina Avdic, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS
Mefloquine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of mild to moderate acute malaria (P. falciparum and P. vivax) caused by chloroquine-resistant, chloroquine-susceptible and multiple-drug-resistant (including sulfadoxine and pyrimethamine-resistant) strains
  • Malaria (P. falciparum and P. vivax) prophylaxis including prophylaxis of chloroquine-resistant strains of P. falciparum.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Treatment of mild to moderate acute malaria (P. falciparum and P. vivax) caused by chloroquine-resistant, chloroquine-susceptible and multiple-drug-resistant (including sulfadoxine and pyrimethamine-resistant) strains
  • Malaria (P. falciparum and P. vivax) prophylaxis including prophylaxis of chloroquine-resistant strains of P. falciparum.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 10, 2021